TwinBeech Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-198,395
| Closed | -$3.1M | – | 835 |
|
|
2024
Q3 | $3.1M | Buy |
198,395
+73,267
| +59% | +$1.15M | 0.06% | 345 |
|
|
2024
Q2 | $2.14M | Sell |
125,128
-3,834
| -3% | -$65.7K | 0.04% | 328 |
|
|
2024
Q1 | $2.02M | Sell |
128,962
-48,439
| -27% | -$757K | 0.04% | 339 |
|
|
2023
Q4 | $2.65M | Sell |
177,401
-254,512
| -59% | -$3.8M | 0.04% | 361 |
|
|
2023
Q3 | $6.98M | Buy |
431,913
+146,737
| +51% | +$2.37M | 0.13% | 208 |
|
|
2023
Q2 | $11.8M | Buy |
285,176
+201,975
| +243% | +$8.38M | 0.23% | 131 |
|
|
2023
Q1 | $5M | Buy |
+83,201
| New | +$5M | 0.1% | 243 |
|
|
2022
Q3 | – | Sell |
-3,014
| Closed | -$209K | – | 752 |
|
|
2022
Q2 | $209K | Sell |
3,014
-7,937
| -72% | -$550K | 0.01% | 470 |
|
|
2022
Q1 | $907K | Sell |
10,951
-41,196
| -79% | -$3.41M | 0.04% | 333 |
|
|
2021
Q4 | $3.92M | Buy |
+52,147
| New | +$3.92M | 0.22% | 127 |
|
|
2020
Q2 | – | Sell |
-23,266
| Closed | -$1.57M | – | 462 |
|
|
2020
Q1 | $1.57M | Buy |
23,266
+18,565
| +395% | +$1.25M | 0.63% | 48 |
|
|
2019
Q4 | $396K | Buy |
+4,701
| New | +$396K | 0.11% | 254 |
|